{
    "clinical_study": {
        "@rank": "166413", 
        "brief_summary": {
            "textblock": "Hepatocellular carcinoma represents 80-90% of primary hepatic malignant tumors. 80% of\n      patients with hepatocellular carcinoma are associated with cirrhosis.\n\n      Chemoembolization is a process in which a chemotherapeutic agent is deposited directly into\n      the hepatic tumor where the principal artery is embolized.\n\n      Bioelectrical impedance bases its evaluation in a model where the body is conformed by two\n      different compartments: fat mass and fat free mass.\n\n      Bioelectrical impedance is complemented by vectorial analysis, which is independent to the\n      state of hydration and is helpful to monitor any changes in corporal composition. It can be\n      used as a control for the interpretation of the bioelectrical impedance."
        }, 
        "brief_title": "Body Composition Analysis in Patients Undergoing Chemoembolization", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Hepatocellular Carcinoma", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Hepatocellular"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with hepato-renal disease\n\n          -  Patients with hepatocellular carcinoma that are put down to radiofrequency\n             ablation\n\n          -  Patients with depression or any psiquiatric disease.\n\n          -  Patients that don't agree to participate in the project.\n\n        Exclusion Criteria:\n\n          -  Patients with hepatocellular carcinoma that are put down to radiofrequency\n             ablation\n\n          -  Patients with depression or any psiquiatric disease.\n\n          -  Patients that don't agree to participate in the project."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "The patients will be recruited from the Radiology Department of a tertiary care center."
            }
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01777698", 
            "org_study_id": "QMECR1"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "body composition", 
            "hepatocellular carcinoma", 
            "chemoembolization"
        ], 
        "lastchanged_date": "March 12, 2014", 
        "location": {
            "contact": {
                "email": "detoal@yahoo.com", 
                "last_name": "Aldo Torre, M.D, M.Sc.", 
                "phone": "54870900", 
                "phone_ext": "2711"
            }, 
            "facility": {
                "address": {
                    "city": "Mexico city", 
                    "country": "Mexico", 
                    "zip": "14000"
                }, 
                "name": "Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n \"Salvador Zubir\u00e1n\""
            }, 
            "investigator": [
                {
                    "last_name": "Aldo Torre, M.D., M.Sc.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Astrid Ruiz-Margain, B.Sci", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Mexico"
        }, 
        "number_of_groups": "1", 
        "official_title": "Body Composition Analysis by Bioelectrical Impedance Vector Analysis in Patients With Hepatocellular Carcinoma Undergoing Chemoembolization.", 
        "overall_contact": {
            "email": "detoal@yahoo.com", 
            "last_name": "Aldo Torre, M.D., M.Sc.", 
            "phone": "54870900", 
            "phone_ext": "2711"
        }, 
        "overall_contact_backup": {
            "email": "astridrm13@gmail.com", 
            "last_name": "Astrid Ruiz-Margain, B.Sci", 
            "phone": "54870900", 
            "phone_ext": "2711"
        }, 
        "overall_official": {
            "affiliation": "Instituto Nacional de Nutrici\u00f3n y Ciencias M\u00e9dicas \"Salvador Zubir\u00e1n\"", 
            "last_name": "Aldo Torre, M.D, M.Sc.", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Mexico: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To evaluate any changes in corporal composition in patients undergoing chemoembolization.", 
            "measure": "Changes in body composition", 
            "safety_issue": "No", 
            "time_frame": "1 hour before treatment, 2 weeks after treatment, and 1 month after treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01777698"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran", 
            "investigator_full_name": "ALDO TORRE DELGADILLO", 
            "investigator_title": "M.D., M.Sc.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}